External application of Siddha medicine- Moosambara patru on Mootu veekam (Swollen Knee joint) – Short term Clinical Trial
Trial Snapshot
- Phase
- Phase 2
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- To assess the changes in the swelling of the subjects by measuring the circumference of the affected joint before and after treatment
Study Overview
Brief Summary
Based on the Case sheet proforma the trial subjects wererecruited for the trial. At first they were sent for screening whether to confirmthe diagnosis. The consent forms signed by the patients were collected and thePatient information sheet was given as per the ethical guidelines. They wereasked to report to the Investigators every 5days once for a consecutive periodof 15days. The recruited patients were enrolled in the register. Theinvestigations were advised as per the protocol. The Moosambara patru25 g ofmedicine was given to the patients with subject I.Dnos. They were asked to Applied the medicine in swollen joint for 5 days mixedwith White Egg yolk as a External therapy .And every visit measuring the swollen knee joints with helpof non elastic inch tap, before and after treatments. Every five days onceMeasurements were done consecutively for a period of 15days treatment.The data generated maintained in the excel sheet.
Study Design
- Study Type
- Interventional
- Allocation
- Not Applicable
- Masking
- Open Label
Eligibility Criteria
- Ages
- 40.00 Year(s) to 65.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •1.Age between 40 years to 65 years 2.Patients with knee joint swelling (Single or Both knees) 3.Pain 4.Joint tenderness 5.Patients willing to give consent to participate in the trial.
Exclusion Criteria
- •1.Age less than 40 years or more than 65 years 2.Patients with Diabetes mellitus/ Hepatic failure/ Renal failure, 3.Any serious underlying infectious conditions and Hematoma 4.History of surgical interventions 5.Patients not willing to give consent to participate in the trial.
Outcomes
Primary Outcomes
To assess the changes in the swelling of the subjects by measuring the circumference of the affected joint before and after treatment
Time Frame: To assess the changes in the swelling of the subjects by measuring the circumference of the affected joint before and after treatment
Secondary Outcomes
- To assess the safety of the trial drug while applying externally